No registrations found.
ID
Source
Brief title
Health condition
Angina Pectoris, Coronary Artery Bypass Grafting (CABG), Coronary artery disease, Sutureless anastomoses
Sponsors and support
Intervention
Outcome measures
Primary outcome
Long term patency of coronary artery bypass grafts.
Secondary outcome
N/A
Background summary
From 2001 to 2004, the research department of cardiothoracic surgery participated in the Multi-center trial Corlink. The study took place in our center and in the Ziekenhuis in Breda. In short, this involved an experimental trial of the applicability of adhesion-free connections in the coronary artery surgery. One of the most important primary endpoints of this study was the so-called short-term patency of coronary bypass grafts (patency = good blood flow in the diversion). The study found that using a coronary angiogram. For more details, I refer you to the Protocol to METC METC # # No M00/1616 & M03/1359. At the time the study was completed successfully.
However, as stated above, patients participated in an experimental trial. Because we always strive for quality care, we believe that the participants in this study are entitled to a long-term control.
Using the 256 multi-slice computed tomography we study long term patency.
The released data we use in the future regarding the use of the mechanical connectors in coronary artery surgery. To date, the long-term patency of these compounds in the coronary vascular assisted surgery has not been described in international literature.
Countries of recruitment > Netherlands.
Study objective
Within long term follow up hand sewn anastomoses in coronary artery bypass grafting are more patent than corlink facilitated anastomoses.
Study design
256 Cardiac CT scan.
Intervention
Participation in Corlink Trial.
N.J. Verberkmoes
Catharina Hospital, Dep. Cardiothoracic Surgery, research and development
Eindhoven 5623 EJ
The Netherlands
+31 (0)40 2398680
nielsverberkmoes@hotmail.com
N.J. Verberkmoes
Catharina Hospital, Dep. Cardiothoracic Surgery, research and development
Eindhoven 5623 EJ
The Netherlands
+31 (0)40 2398680
nielsverberkmoes@hotmail.com
Inclusion criteria
Participation Corlink Trial (METC #M00/1616 & nr. METC#M03/1359).
Exclusion criteria
1. Atriumfibrillation;
2. Severe renal insufficiency;
3. Coronary angiogram (diagnostic/intervention) in past year;
4. Cardiac CT scan in past year;
5. Re-CABG.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2451 |
| NTR-old | NTR2567 |
| Other | METC Catharina Ziekenhuis : M10-1053 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |